News, Money and Drugs for Tuesday, July 14, 2009
July 14, 2009 at 6:30 pm EST | Tags: News
Today’s big news was Noven Pharmaceuticals. The transdermal drug maker was acquired by rival Japanese firm Hisamitsu Pharmaceutical for $430M. Noven was advised by elite law firm Cravath, Swaine & Moore. [DealBook]
Oscient Pharmaceuticals No. 1: Bankrupt! [Reuters]
Oscient Pharmaceuticals No. 2: No. 2 drug Sold! [Xconomy]
HPV data boosts Sequenom (SQNM) stock. [Reuters]
ReadClosely: Solvay/Abbott deal in the works? [The Deal]
Dear Shire, please tell us this is not true… [BNET Pharma]
Thumbs up for Wyeth – in Chile. [AP]
Thumbs down for Watson – in the U.S. [Pharmalive]
J&J talks Tylenol, Elan and some other stuff…zzzzzz. [Pharmalive]
Last, but not least, the most interesting story of the day that didn’t get mindlessly copied and pasted everywhere was Wynonna Judd. Yeah, Wynnona Judd. Judd put on a private concert on Saturday at the Country Music Hall of Fame in Nashville in honor of GSK’s weight loss drug alli. Judd is alli’s spokesperson and has lost 2 dress sizes since starting. The concert was exclusively for 50 sweepstakes winners, most of which have also lost weight on the drug. Where’s Biggie Smalls when you need him??? [PR Newswire]
Anonymous Tip? Comments? Contact us: hr AT iguanabio DOT com



